GPCR Institutional Ownership

Structure Therapeutics Inc.

Latest close $50.53 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Feb 5, 2026

Public consensus preview Accumulation leaning 70/100 institutional research score

2 tracked institutions Latest filing Feb 5, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$15.80 52-week high$94.90

Latest close $50.53 43.9% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Dec 31, 2025

Capital Research Global Investors May 13, 2025 filed

Fidelity / FMR Aug 6, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 4 parsed filing(s) · 1 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Fidelity / FMR CIK0000315066	Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment	Reported reduction	28.2M -2.9M	13.20% -1.80 pts	$53.67	$52.62	$50.53
Fidelity / FMR CIK0000315066	Dec 31, 2025 observed Feb 5, 2026 filed · 36d Schedule 13G amendment	Earliest Schedule 13G amendment found	31.1M	15.00%	$69.55	$73.21	$50.53
Capital Research Global Investors CIK0001422848	Mar 31, 2025 observed May 13, 2025 filed · 43d Schedule 13G amendment	Reported accumulation	172.0M +161.4M	12.00% +5.80 pts	$17.31	$23.89	$50.53

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

VOR VOR BIOPHARMA INC 70/100 Accumulation leaning TRVI TREVI THERAPEUTICS INC 70/100 Accumulation leaning ZVRA ZEVRA THERAPEUTICS, INC. 70/100 Accumulation leaning SPCE VIRGIN GALACTIC HOLDINGS INC 70/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026